In this STEP KO strain, a neo cassette replaces the catalytic site of the protein tyrosine phosphatase, non-receptor type 5 (Ptpn5) gene, abolishing gene expression. These mice may be useful for studying the role of STEP in regulating synaptic plasticity in Alzheimer's Disease.
Paul Lombroso, Yale University School of Medicine
Genetic Background | Generation |
---|---|
|
Allele Type | Gene Symbol | Gene Name |
---|---|---|
Targeted (Null/Knockout) | Ptpn5 | protein tyrosine phosphatase, non-receptor type 5 |
In this STEP KO strain, a neo cassette replaces the catalytic site of the protein tyrosine phosphatase, non-receptor type 5 (Ptpn5) gene, abolishing gene expression. Homozygotes are viable, fertile, and normal in size. Striatal enriched protein phosphatase (STEP) is a neuron-specific tyrosine phosphatase which regulates synaptic plasticity following glutamatergic and dopaminergic input. Expressed mainly in the striatum, hippocampus, amygdala, and cortex of the brain, glutamate-activated STEP controls synaptic plasticity through limiting the duration of ERK 1/2 MAP kinase activity and by endocytosis of glutamate receptors. Activation of ERK1/2 in STEP-expressing regions of the brain is required for memory formation and learning. STEP levels are also shown to be increased in prefrontal cortex of Alzheimer's Disease (AD) models. Homozygous STEP KO mice lack expression of all STEP isoforms, and exhibit enhanced phosphorylation of ERK1/2 in the striatum, hippocampus, and amygdala, with slight elevation in the lateral septum. Heterozygous mice display a 50% reduction in STEP expression when compared to wildtype littermates. This decrease in STEP levels reverses cognitive and cellular deficits observed in AD mice, and blocks internalization of glutamate receptors. These mice may be useful for studying the role of STEP in regulating synaptic plasticity in Alzheimer's Disease.
A targeting vector was designed to replace 1284 bp of genomic sequence, including the catalytic site, of the protein tyrosine phosphatase, non-receptor type 5 (Ptpn5) gene with a neomycin resistance (neo) cassette. The construct was electroporated into 129-derived embryonic stem (ES) cells. Correctly targeted ES cells were injected into C57BL/6 blastocysts and the resulting chimeric mice were bred to C57BL/6NCrl mice to generate a colony of STEP KO mice. These mice were backcrossed 10 generations to C57BL/6NCrl background. Upon arrival at The Jackson Laboratory, mice were bred to C57BL/6NJ (Stock No. 005304) for at least one generation to establish the colony.
Allele Name | targeted mutation 1, Paul J Lombroso |
---|---|
Allele Type | Targeted (Null/Knockout) |
Allele Synonym(s) | STEP- |
Gene Symbol and Name | Ptpn5, protein tyrosine phosphatase, non-receptor type 5 |
Gene Synonym(s) | |
Strain of Origin | 129 |
Chromosome | 7 |
Molecular Note | 1284 bp of genomic sequence encoding the catalytic site was replaced with a neo cassette. The absence of protein expression was confirmed by western blot analysis on brain extracts. |
Mutations Made By | Paul Lombroso, Yale University School of Medicine |
When maintaining a live colony, homozygous mice may be bred together.
When using the B6N.129-Ptpn5tm1Pjlo/J mouse strain in a publication, please cite the originating article(s) and include JAX stock #016556 in your Materials and Methods section.
Facility Barrier Level Descriptions
Service/Product | Description | Price |
---|---|---|
Heterozygous for Ptpn5<tm1Pjlo> |
Frozen Mouse Embryo | B6N.129-Ptpn5<tm1Pjlo>/J Frozen Embryo | $2595.00 |
Frozen Mouse Embryo | B6N.129-Ptpn5<tm1Pjlo>/J Frozen Embryo | $2595.00 |
Frozen Mouse Embryo | B6N.129-Ptpn5<tm1Pjlo>/J Frozen Embryo | $3373.50 |
Frozen Mouse Embryo | B6N.129-Ptpn5<tm1Pjlo>/J Frozen Embryo | $3373.50 |
Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.
The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project. We do not guarantee breeding performance and therefore suggest that investigators order more than one breeding pair to avoid delays in their research.
What information were you hoping to find through your search?
How easy was it to find what you were looking for?
We may wish to follow up with you. Enter your email if you are happy for us to connect and reachout to you with more questions.
Please Enter a Valid Email Address
Thank you for sharing your feedback! We are working on improving the JAX Mice search. Come back soon for exciting changes.